Heart Rate Variability Indicates Health
Heart rate variability, measured by wearables, indicates health, stress, and exercise capacity, with higher variability generally signifying better health.

Heart Rate Variability Offers Health Insights Wearable technology is increasingly utilizing heart rate variability (HRV) as a key metric to assess an individual's health, stress levels, and exercise capacity. This physiological measure, which quantifies the micro-fluctuations in the time between heartbeats, provides insights into the balance between the body's stress and relaxation responses.
A higher HRV generally indicates better cardiovascular health and a more adaptable nervous system, capable of efficiently transitioning between states of activity and rest. Conversely, a lower HRV can suggest increased stress or fatigue. While a healthy heart maintains some variation, extremely irregular heartbeats are classified as arrhythmias, which can lead to serious complications such as stroke or heart failure.
HRV scores vary significantly by age, fitness level, and sex. For instance, data from one wearable brand indicates an average HRV of 78 milliseconds for 25-year-olds, decreasing to 44 milliseconds for 55-year-olds among its active user base. This metric is distinct from resting heart rate, where a lower number typically signifies better fitness. The ability of the heart to quickly adjust its rate and blood pressure in response to environmental or physical demands is reflected in a higher HRV, demonstrating the nervous system's flexibility.
More stories
- Donor-specific genomes reveal 1,790 chromatin hotspots
- Ant genomes point to mobile DNA as size driver
- Strength-focused exercise after 50 reframes heart plans
- Flu visits double as early season puts vaccines in focus
- Hurricane Isaias halts Gulf output; US approves oil relief
- Unduliner reaches 0.897 accuracy in cancer-genome preprint
- Type 2 Diabetes: Blood Sugar Management
- GLP-1 Medications: Emerging Side Effects and Data Limitations
- Blood Test Identifies Alzheimer's Biomarker Years Before Scans
- GLP-1 Medications Primarily Reduce Fat, Not Muscle Mass
Latest news
- Bandai Namco sets 2027 cross-play test for Sparking Zero
- Washington weighs a harder bargain for Israel’s next defense aid pact
- Turkey-Israel spat puts Washington’s Gaza diplomacy in a tighter corner
- Bangladesh MICS7 shows high lead in 38.5% of children
- Mashreq CEO Abdelaal joins 15-member Swift board
- Sudan strikes kill 112, rights group says
- Ticketory says six-month bookings exceed €550,000
- Deadlock’s Solomon hides 8-to-32 chess reload boards

